Glaxo Cutivate
Executive Summary
Fluticasone propionate cream .005% is approved by FDA June 17 for use in pediatric patients age three months or older. The product was previously approved for the relief of the inflammatory and pruritic manifestations of corticoid-responsive dermatoses in adults
You may also be interested in...
Botox Cosmetic Warning Letter: FDA Frowns On Broad Claims, Wants Correction
FDA is asking Allergan to correct information in its Botox Cosmetic DTC print campaign regarding the scope of the product's indication
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011